FATE THERAPEUTICS INC

FATE · NASDAQ

Updated at 2026-10-14 09:06:44

$2.00-6.1%
Today's High
$2.13
Today’s Low
$1.98
FATE THERAPEUTICS INC (FATE) Stock Price & Market Data
Search empty state illustration
...

Candlestick trends are for reference. Refer to the trading page for actual data.

Key Statistics

Previous Open
$2.13
Previous Close
$2.13
Volume
616.84K
Market Cap
$255.21M
P/E Ratio
--
EPS
$-1.05

Previous Day Range

$2.10$2.18

52-Week Range

$0.95$3.23

Company Overview

Sector
HEALTHCARE
Industry
Biotechnology
Sub-industry
BIOTECHNOLOGY
Headquarters
12278 SCRIPPS SUMMIT DRIVE, SAN DIEGO, CA, UNITED STATES, 92131
Country
US
Listing Date
2013-10-01
Fiscal Year End
December
Shares Outstanding
116.56M
CIK
0001434316

Fate Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops programmed cellular immunotherapies for cancer and immune disorders globally. The company is headquartered in San Diego, California.

Financial Metrics

--

FAQs

Risk Warning

Stock prices can be highly volatile and may rise or fall sharply in a short period. Digital asset and derivative products involve additional risks such as leverage and liquidity. Content on this page is for reference only and does not constitute investment advice. Product availability and access may vary by region and applicable regulations.